Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarcosine for individuals at risk for schizophrenia
NCT00276263Phase 2Withdrawn
- Sponsor
- Herzog Hospital
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sarcosine in schizophrenia, sponsored by Herzog Hospital. Planned start Aug 2006; status: withdrawn.
02
Drugs
sarcosine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00276263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276263.